INLIF LIMITED Reports Fiscal Year 2024 Financial Results

    0
    112

    QUANZHOU, China, April 30, 2025 /PRNewswire/ — INLIF LIMITED (Nasdaq: INLF) (the “Company” or “INLIF”), a company engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms, today announced its financial results for the year ended December 31, 2024.

    Mr. Rongjun Xu, the chief executive officer of INLIF, remarked, “We are thrilled to report the performance for fiscal year 2024, with growth recorded across revenue, gross profit, and net income. This success was fueled by sustained demand from existing clients and new customers acquired through our strategic marketing initiatives. Our strategic expansion also played a pivotal role in driving sales growth and penetrating new sectors and emerging markets. These combined efforts resulted in a 25.26% year-over-year increase in revenue. As sales increased, our gross margin declined slightly to 28.83%, which contributed to a 9.49% increase in gross profit, highlighting our profitability and effective cost control measures.

    “In preparation for our Nasdaq listing and to unlock greater opportunities in new markets, we launched proactive marketing campaigns and offered attractive incentive commissions to enhance brand recognition and order acquisition. These efforts included participation in exhibitions across China and exploration of overseas markets, particularly in Southeast Asia and India. Meanwhile, we have supported our revenue growth with only a moderate increase in operational costs. We continued to invest in research and development, and we plan to accelerate the acquisition of talents, patents, and technologies to meet the evolving and diversifying needs of the market.

    “Thanks to the outstanding efforts of our team and the strong execution of our strategic initiatives, net income rose by 18.78% during our first financial report post-listing. Looking ahead, we anticipate opportunities for continued growth and development, supported by the enhanced visibility and access to capital provided by our Nasdaq listing. In addition, the rise of emerging technology innovations and the increasing adoption of automation infrastructure are expected to significantly accelerate growth in the manipulator arms industry. We are confident that our proactive and pragmatic business strategies will place us on a sustainable and thriving path, delivering long-term value to the Company and our shareholders.”

    Fiscal Year 2024 Financial Highlights 

    • Net revenue was $15.80 million for fiscal year 2024, representing an increase of 25.26% from $12.61 million for fiscal year 2023.
    • Gross profit was $4.55 million for fiscal year 2024, representing an increase of 9.49% from $4.16 million for fiscal year 2023.
    • Gross profit margin was 28.83% for fiscal year 2024, compared to 32.98% for fiscal year 2023.
    • Net income was $1.61 million for fiscal year 2024, representing an increase of 18.78% from $1.35 million for fiscal year 2023.
    • Basic and diluted earnings per share were $0.13 for fiscal year 2024, compared to $0.11 for fiscal year 2023.

    Fiscal Year 2024 Financial Results 

    Net Revenue

    Net revenue was $15.80 million for fiscal year 2024, representing an increase of 25.26% from $12.61 million for fiscal year 2023. The increase was primarily attributable to (i) an increase in sales of manipulator arms, including installation and warranty services, by approximately $0.51 million; (ii) an increase in sales of manipulator arms accessories by approximately $0.44 million; (iii) an increase in sales of raw materials and scraps by approximately $2.27 million; and (iv) a decrease in sales of installation services by approximately $0.04 million.

    • Sales of manipulator arms and installation and warranty services were $10.33 million for fiscal year 2024, representing an increase of 5.23% from $9.82 million for fiscal year 2023.
    • Sales of accessories were $1.44 million for fiscal year 2024, representing an increase of 44.08% from $1.00 million for fiscal year 2023.
    • Sales of raw materials and scraps were $3.93 million for fiscal year 2024, representing an increase of 136.61% from $1.66 million for fiscal year 2023.
    • Sales of installation services were $95,442 for fiscal year 2024, representing a decrease of 29.14% from $134,697 for fiscal year 2023.

    Cost of Revenue

    Cost of revenue was $11.24 million for fiscal year 2024, representing an increase of 33.03% from $8.45 million for fiscal year 2023. The increase was primarily attributable to the Company’s business growth and an increase in sales resulting in an increase in costs accordingly.

    Gross Profit and Gross Profit Margin

    Gross profit was $4.55 million for fiscal year 2024, representing an increase of 9.49% from $4.16 million for fiscal year 2023. The increase mainly due to (i) an increase in gross profit from sales of manipulator arms, including installation and warranty services, by approximately $0.47 million; (ii) a decrease in gross profit from sales of manipulator arms accessories by approximately $0.11 million; (iii) an increase in gross profit from sales of raw materials and scraps by approximately $0.06 million; and (iv) a decrease in gross profit from sales of installation services by approximately $0.03 million.

    Gross profit margin was 28.83% for fiscal year 2024, compared to 32.98% for fiscal year 2023.

    Operating Expenses

    Operating expenses were $3.27 million for fiscal year 2024, representing an increase of 17.74% from $2.77 million for fiscal year 2023.

    • Selling expenses were $0.94 million for fiscal year 2024, representing an increase of 36.46% from $0.69 million for fiscal year 2023. The increase was mainly due to (i) an increase in exhibition expenses by approximately $0.12 million, resulting from participation in an additional four exhibitions across four cities in China in 2024; (ii) an increase in salary by approximately $0.12 million, as the growth in revenue has led to higher commissions for sales personnel, alongside the addition of three sales representatives in 2024 compared to 2023; and (iii) an increase in transportation fees by approximately $0.19 million, due to increase of sales to customers from other provinces, such as Guangdong, Zhejiang, and Jiangsu, resulting in a rise in related transportation costs.
    • General and administrative expenses were $0.76 million for fiscal year 2024, representing an increase of 5.58% from $0.72 million for fiscal year 2023. The increase was mainly due to an increase in consulting fees for external public relations and internal control.
    • Research and development expenses were $1.56 million for fiscal year 2024, representing an increase of 14.76% from $1.36 million for the same period of last year. The increase was primarily attributable to increased investment in research and corresponding material consumption to enhance the quality and performance of manipulator arms.

    Net Income

    Net income was $1.61 million for fiscal year 2024, representing an increase of 18.78% from $1.35 million for fiscal year 2023.

    Basic and Diluted Earnings per Share

    Basic and diluted earnings per share were $0.13 for fiscal year 2024, compared to $0.11 for fiscal year 2023.

    Financial Condition

    As of December 31, 2024, the Company had cash and cash equivalents of $2.47 million, compared to $0.60 million as of December 31, 2023.

    Net cash provided by operating activities was $1.58 million for fiscal year 2024, compared to $0.40 million for fiscal year 2023.

    Net cash provided by investing activities was $0.32 million for fiscal year 2024, compared to net cash used in investing activities of $0.22 million for fiscal year 2023.

    Net cash provided by financing activities was $0.22 million for fiscal year 2024, compared to $0.46 million for fiscal year 2023.

    Recent Development

    On January 3, 2025, the Company completed its initial public offering of 2,000,000 ordinary shares at a public offering price of US$4.00 per share. The Company’s ordinary shares began trading on the Nasdaq Capital Market on January 2, 2025, under the ticker symbol “INLF.”

    About INLIF LIMITED

    Through its operating entity in the People’s Republic of China, Ewatt Robot Equipment Co. Ltd., established in September 2016, INLIF is engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms. It is also a provider of installation services and warranty services for manipulator arms, and accessories and raw materials for manipulator arms. The Company produces an extensive portfolio of injection molding machine-dedicated manipulator arms, including transverse single and double-axis manipulator arms, transverse and longitudinal multi-axis manipulator arms, and large bullhead multi-axis manipulator arms, all developed by itself. For more information, please visit the Company’s website: https://ir.yiwate88.com/.

    Forward-Looking Statements

    Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can find many (but not all) of these statements by the use of words such as “approximates,” “believes,” “hopes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “plans,” “will,” “would,” “should,” “could,” “may” or other similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. These statements are subject to uncertainties and risks, including, but not limited to, the uncertainties related to market conditions, and other factors discussed in the “Risk Factors” section of the registration statement filed with the U.S. Securities and Exchange Commission (the “SEC“). Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and other filings with the SEC. Additional factors are discussed in the Company’s filings with the SEC, which are available for review at www.sec.gov.

    For investor and media inquiries, please contact:

    INLIF LIMITED
    Investor Relations Department
    Email: ir@yiwate88.com

    Ascent Investor Relations LLC

    Tina Xiao
    Phone: +1-646-932-7242
    Email: investors@ascent-ir.com 

    INLIF LIMITED

    CONSOLIDATED BALANCE SHEETS

    (Expressed in U.S. Dollars, except for the number of shares)

    As of 
    December 31, 
    2024

    As of 
    December 31, 
    2023

    ASSETS

    CURRENT ASSETS:

    Cash and cash equivalents

    $

    2,467,638

    $

    598,933

    Accounts receivable, net

    3,840,120

    3,789,214

    Inventories

    5,300,458

    4,493,042

    Deferred offering costs, current

    1,482,558

    Prepayments and other current assets

    159,570

    142,095

    Amounts due from related parties

    1,030

    352,118

    TOTAL CURRENT ASSETS

    $

    13,251,374

    $

    9,375,402

    NON-CURRENT ASSETS:

    Property, plant, and equipment, net

    $

    3,037,312

    $

    3,397,167

    Land-use rights, net

    2,130,164

    2,237,684

    Intangible assets, net

    43,773

    50,297

    Deferred offering costs, non-current

    960,241

    Deferred tax assets

    5,169

    452

    TOTAL NON-CURRENT ASSETS

    $

    5,216,418

    $

    6,645,841

    TOTAL ASSETS

    $

    18,467,792

    $

    16,021,243

    LIABILITIES

    CURRENT LIABILITIES:

    Accounts payable

    $

    3,132,613

    $

    2,546,418

    Bank loans

    4,630,581

    3,662,023

    Contract liabilities

    1,712

    65,073

    Accrued expenses and other payables

    222,247

    259,648

    Income taxes payable

    27,337

    12,058

    Amounts due to related parties

    186,768

    513,018

    TOTAL CURRENT LIABILITIES

    $

    8,201,258

    $

    7,058,238

    TOTAL LIABILITIES

    $

    8,201,258

    $

    7,058,238

    COMMITMENTS AND CONTINGENCIES (NOTE 19)

    SHAREHOLDERS’ EQUITY

    Ordinary shares ($0.0001 par value, 500,000,000 shares authorized, 12,500,000
         shares issued and outstanding as of December 31, 2024 and 2023)*

    $

    1,250

    $

    1,250

    Additional paid-in capital

    7,037,503

    7,037,503

    Statutory reserve

    361,083

    200,229

    Retained earnings

    3,201,818

    1,756,183

    Accumulated other comprehensive loss

    (335,120)

    (32,160)

    TOTAL SHAREHOLDERS’ EQUITY

    $

    10,266,534

    $

    8,963,005

    TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

    $

    18,467,792

    $

    16,021,243

    *     The share amounts are presented on a retrospective basis.

    INLIF LIMITED

    CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME

    (Expressed in U.S. Dollars, except for the number of shares)

    Years ended December 31,

    2024

    2023

    2022

    Revenues

    15,796,983

    12,610,873

    6,652,308

    Cost of revenues

    (11,242,817)

    (8,451,336)

    (4,358,426)

    Gross profit

    4,554,166

    4,159,537

    2,293,882

    Operating expenses:

    Selling expenses

    (938,941)

    (688,064)

    (396,421)

    General and administrative expenses

    (764,530)

    (724,147)

    (742,620)

    Research and development expenses

    (1,563,059)

    (1,362,058)

    (504,711)

    Total operating expenses

    (3,266,530)

    (2,774,269)

    (1,643,752)

    Operating income

    1,287,636

    1,385,268

    650,130

    Other income (expenses):

    Interest income

    3,274

    6,884

    2,625

    Interest expenses

    (196,304)

    (146,386)

    (82,672)

    Other income, net

    531,198

    110,159

    15,010

    Other expense, net

    (8,370)

    (17,410)

    (44,274)

    Exchange gain (loss)

    3,893

    25,344

    (3,687)

    Total other income (expenses), net

    333,691

    (21,409)

    (112,998)

    Income before income tax

    1,621,327

    1,363,859

    537,132

    Income tax (expenses) benefits

    (14,838)

    (11,348)

    423

    Net income

    1,606,489

    1,352,511

    537,555

    Comprehensive income

    Net income

    1,606,489

    1,352,511

    537,555

    Foreign currency translation adjustments, net of tax

    (302,960)

    (227,278)

    187,942

    Comprehensive income

    1,303,529

    1,125,233

    725,497

    Earnings per share, basic and diluted

    0.13

    0.11

    0.04

    Weighted average number of shares*

    12,500,000

    12,500,000

    12,500,000

    *     The share amounts are presented on a retrospective basis.

    INLIF LIMITED

    CONSOLIDATED STATEMENTS OF CASH FLOWS

    (Expressed in U.S. Dollars, except for the number of shares)

    For the years ended

    December 31,

    2024

    2023

    2022

    Cash flows from operating activities:

    Net income

    1,606,489

    1,352,511

    537,555

    Adjustments to reconcile net income (loss) to net cash used in operating 
         activities:

    Depreciation and amortization

    347,977

    367,029

    388,233

    Allowance for (reversal of) credit losses

    (154)

    (19,930)

    15,975

    Loss on disposal of property, plant, and equipment

    5,432

    Deferred tax assets

    (423)

    Changes in operating assets and liabilities:

    Accounts receivable

    (50,752)

    (1,552,991)

    (716,876)

    Intangible assets

    (53,086)

    Inventories

    (807,416)

    (2,025,725)

    1,093,218

    Prepayments and other current assets

    (17,474)

    94,160

    170,093

    Accounts payable, trade

    586,195

    2,057,775

    (103,240)

    Contract liabilities

    (63,361)

    65,073

    (137,699)

    Other payables and accrued liabilities

    (37,401)

    98,485

    (7,507)

    Tax payable

    15,279

    11,505

    (301)

    Net cash provided by operating activities

    1,579,382

    400,238

    1,239,028

    Cash flows from investing activities:

    Purchase of property, plant, and equipment

    (25,759)

    (219,121)

    (18,165)

    Disposal of property, plant, and equipment

    989

    Amount loan to related parties

    (1,025)

    Proceeds from repayment by related parties

    347,428

    Net cash provided by (used in) investing activities

    320,644

    (218,132)

    (18,165)

    Cash flows from financing activities:

    Capital Contributions

    6,760,538

    Proceeds from short-term loans

    7,143,130

    3,671,841

    2,526,378

    Repayment of short-term loans

    (6,059,153)

    (2,400,819)

    (1,486,105)

    Deferred offering costs

    (522,318)

    (919,207)

    (42,060)

    Amount financed from related parties

    181,116

    977,418

    515,678

    Amount repaid to related parties

    (518,379)

    (865,770)

    (9,993,772)

    Net cash provided by (used in) financing activities

    224,396

    463,463

    (1,719,343)

    Effect of exchange rate changes

    (255,717)

    (131,597)

    397,892

    Net increase (decrease) in cash

    1,868,705

    513,972

    (100,588)

    Cash and cash equivalents at beginning of the year

    598,933

    84,961

    185,549

    Cash and cash equivalents at end of the year

    2,467,638

    598,933

    84,961

    Supplemental disclosures of cash flows information:

    Cash paid for income taxes

    1,707

    475

    303

    Cash paid for interest expense

    191,859

    143,727

    82,672